MARKET

PGEN

PGEN

Precigen Inc
NASDAQ
4.420
-0.180
-3.91%
After Hours: 4.370 -0.05 -1.13% 19:23 05/15 EDT
OPEN
4.540
PREV CLOSE
4.600
HIGH
4.630
LOW
4.360
VOLUME
3.62M
TURNOVER
--
52 WEEK HIGH
5.47
52 WEEK LOW
1.260
MARKET CAP
1.58B
P/E (TTM)
-3.5709
1D
5D
1M
3M
1Y
5Y
1D
A Look At Precigen (PGEN) Valuation After PAPZIMEOS Revenue Ramp And Cash Flow Target Update
Simply Wall St · 9h ago
Precigen Earnings Call Highlights PAPZIMEOS Launch Surge
TipRanks · 1d ago
Precigen jumps after Q1 beat as Papzimeos launch momentum takes hold
Seeking Alpha · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Advanced Energy, Bel Fuse, Cerebras
Reuters · 2d ago
Precigen Stock Climbs After Strong 1Q for Papzimeos Sales
Dow Jones · 2d ago
Precigen Price Target Raised to $11.00/Share From $9.00 by Citizens
Dow Jones · 2d ago
Precigen Is Maintained at Market Outperform by Citizens
Dow Jones · 2d ago
Citizens Maintains Market Outperform on Precigen, Raises Price Target to $11
Benzinga · 2d ago
More
About PGEN
Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company developing gene and cell therapies for improving outcomes for patients with unmet medical needs. The Company’s proprietary technology platforms develop product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company’s segments include Biopharmaceuticals and Exemplar. The Biopharmaceuticals segment is primarily comprised of the Company's legal entities as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. The Exemplar is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar, its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

Webull offers Precigen Inc stock information, including NASDAQ: PGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PGEN stock methods without spending real money on the virtual paper trading platform.